What is the recommended management for acne neonatum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acne Neonatum

Acne neonatum is typically a mild and self-limiting condition that usually resolves spontaneously, requiring only gentle cleansing with mild soap and water in most cases. 1

Clinical Characteristics

  • Acne neonatum occurs between the second and fourth weeks of life in approximately 20% of newborns, with a male predominance (male-female ratio of 4.5:1) 1
  • Primary lesions include open and closed comedones that may evolve into papules, erythematous pustules, and rarely nodules and cysts 1
  • Common locations include the forehead, cheeks, chin, and eyelids, occasionally spreading to the scalp, neck, and trunk 1, 2
  • The condition is caused by elevated production of placental and neonatal androgens, leading to enlarged sebaceous glands and increased sebum production 1, 3

Treatment Approach

First-Line Management

  • For most cases, gentle cleansing with mild soap and water is sufficient as the condition is self-limiting 1
  • No active treatment is required for mild cases as spontaneous resolution typically occurs within a few months 2

For Persistent or Moderate Cases

  • For comedonal lesions (open and closed comedones), consider:
    • Topical retinoids at low concentration 1
    • 20% azelaic acid 1
  • For inflammatory lesions (papules and pustules), consider:
    • Topical antibiotics such as erythromycin 1, 4

For Severe Cases

  • Severe and persistent cases may require:
    • Topical antibiotics such as erythromycin applied twice daily to affected areas 5, 4
    • Systemic erythromycin in selected cases with widespread inflammatory lesions 4
    • In rare, severe cases that don't respond to other treatments, low-dose isotretinoin (0.5 mg/kg) may be considered under specialist supervision 4

Important Considerations

  • Severe or persistent acne neonatum warrants further investigation to rule out underlying conditions such as congenital adrenal hyperplasia or virilizing tumors 1, 6
  • When using topical erythromycin, avoid contact with eyes and mucous membranes 5
  • Topical treatments should be used cautiously to avoid cumulative irritancy effects, especially with peeling or abrasive agents 5
  • The use of antibiotics should be limited to minimize the risk of developing antibiotic-resistant organisms 5
  • Drying and peeling from topical treatments can be controlled by reducing application frequency 5

Follow-up Recommendations

  • Most cases resolve spontaneously within 1-4 months 2
  • If acne persists beyond 6 months or is unusually severe, consider referral to a pediatric dermatologist to evaluate for underlying endocrine disorders 1, 6
  • Monitor for potential scarring in moderate to severe cases, as this may indicate need for more aggressive intervention 6

Common Pitfalls to Avoid

  • Overtreatment of a self-limiting condition 1
  • Using adult-strength acne medications on sensitive neonatal skin 5
  • Failure to recognize severe or persistent cases that may indicate underlying hormonal disorders 1, 6
  • Using topical antibiotics as monotherapy, which increases risk of bacterial resistance 7

References

Research

[Acne in the newborn.].

Boletin medico del Hospital Infantil de Mexico, 2021

Research

Acne neonatorum: a study of 22 cases.

International journal of dermatology, 1999

Research

[Acne neonatorum/acne infantum].

Ugeskrift for laeger, 2000

Research

Acne vulgaris in children and adolescents.

Minerva pediatrica, 2011

Guideline

Acne Treatment Guidelines for Teens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.